Related Experiment Videos
Direct n.m.r. evidence for substrate-induced conformational changes in a beta-lactamase
M Jamin1, C Damblon, A M Bauduin-Misselyn
1Laboratoire d'Enzymologie, Université de Liège, Belgium.
The Biochemical Journal
|July 1, 1994
Summary
Beta-lactam antibiotics like cefoxitin are poorly processed by Bacillus licheniformis beta-lactamase. Nuclear magnetic resonance (NMR) revealed structural changes in the enzyme during stable acyl-enzyme complex formation with cefoxitin and moxalactam.
Area of Science:
- Biochemistry
- Enzymology
- Structural Biology
Background:
- Beta-lactam antibiotics are crucial in treating bacterial infections.
- Beta-lactamases are enzymes that confer antibiotic resistance by hydrolyzing beta-lactam rings.
- Bacillus licheniformis beta-lactamase (BLA) is a key enzyme in understanding antibiotic resistance mechanisms.
Purpose of the Study:
- To investigate the interaction between cefoxitin, a beta-lactam antibiotic, and Bacillus licheniformis beta-lactamase.
- To characterize the acyl-enzyme intermediate formed during the enzymatic reaction.
- To explore the potential of structural studies for understanding enzyme-inhibitor interactions.
Main Methods:
- Kinetic analysis of the enzyme-cefoxitin system.
- Attempted crystallographic studies of the acyl-enzyme complex.
- Nuclear Magnetic Resonance (NMR) spectroscopy to observe the acyl-enzyme intermediate.
Main Results:
- Cefoxitin and similar antibiotics are poor substrates for Bacillus licheniformis beta-lactamase.
- Crystallographic studies failed to detect a stable crystalline acyl-enzyme complex.
- NMR spectroscopy directly observed stable acyl-enzyme complexes with cefoxitin and moxalactam, showing distinct spectral modifications indicative of enzyme structural changes.
Conclusions:
- The interaction between cefoxitin/moxalactam and BLA forms a stable acyl-enzyme intermediate.
- NMR is a valuable tool for studying enzyme-antibiotic interactions and structural dynamics, even when crystallography is challenging.
- The observed structural modifications provide insights into the mechanism of beta-lactamase inhibition and resistance.